SCHEMBL8934476

SCHEMBL8934476

O=c1oc2ccc(Cl)cc2c(O)c1CCCOc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 5/20 0.61
MCL1 Q07820 4/20 0.49
MAOA P21397 1/20 0.49
MGAM O43451 2/20 0.43
MEN1 O00255 1/20 0.43
ABCB11 O95342 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
PDE4D Q08499 1/20 0.43
PCSK7 Q16549 1/20 0.43
GPR35 Q9HC97 1/20 0.43
KCNA3 P22001 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8945418 0.87 NQO1 (0.62) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL8945547 0.86 NQO1 (0.55) NQO1MCL1MEN1ABCB11ALDH1A1
SCHEMBL6957985 0.85 NQO1 (0.60) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL8945691 0.85 VKORC1 (0.52) NQO1MCL1MEN1ABCB11ALDH1A1
SCHEMBL8945414 0.84 NQO1 (0.53) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL8945266 0.79 NQO1 (0.61) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL3275885 0.79 NQO1 (0.76) NQO1MAOAMGAMMEN1ABCB11
SCHEMBL8945405 0.76 VKORC1 (0.50) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL8934490 0.76 VKORC1 (0.68) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL8945572 0.76 NQO1 (0.55) NQO1MEN1ABCB11ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed
US-5510375-A VIRICIDES TREATING INFECTION CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS AND AIDS WARNER-LAMBERT COMPANY (US) 1996-04-23 US disclosed